Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Mucosa | 18 | 2009 | 35 | 1.640 |
Why?
|
| Pyloric Antrum | 20 | 1998 | 21 | 1.380 |
Why?
|
| Gastrins | 22 | 1998 | 28 | 1.330 |
Why?
|
| Calcitonin Gene-Related Peptide | 12 | 2004 | 30 | 1.250 |
Why?
|
| Colitis | 4 | 2013 | 54 | 1.200 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2009 | 45 | 1.030 |
Why?
|
| Acetylcysteine | 3 | 2013 | 24 | 0.950 |
Why?
|
| Capsaicin | 5 | 2004 | 18 | 0.880 |
Why?
|
| Somatostatin | 11 | 2003 | 25 | 0.860 |
Why?
|
| Neurons, Afferent | 5 | 2004 | 64 | 0.840 |
Why?
|
| Mesalamine | 3 | 2008 | 5 | 0.840 |
Why?
|
| Rats | 30 | 2008 | 1587 | 0.750 |
Why?
|
| Stomach Ulcer | 3 | 2009 | 6 | 0.740 |
Why?
|
| Hamartoma | 3 | 2008 | 13 | 0.700 |
Why?
|
| Transforming Growth Factor alpha | 4 | 2006 | 7 | 0.680 |
Why?
|
| Nitric Oxide | 3 | 2008 | 152 | 0.660 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2008 | 554 | 0.660 |
Why?
|
| Jejunal Neoplasms | 2 | 2008 | 4 | 0.560 |
Why?
|
| Gastrointestinal Stromal Tumors | 2 | 2008 | 12 | 0.560 |
Why?
|
| Gastric Acid | 6 | 2006 | 19 | 0.530 |
Why?
|
| Male | 42 | 2024 | 13772 | 0.510 |
Why?
|
| ErbB Receptors | 2 | 2007 | 100 | 0.500 |
Why?
|
| Free Radical Scavengers | 2 | 2013 | 23 | 0.490 |
Why?
|
| Enema | 2 | 2013 | 7 | 0.470 |
Why?
|
| Colonic Diseases | 3 | 2005 | 10 | 0.470 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 167 | 0.450 |
Why?
|
| Animals | 37 | 2013 | 10583 | 0.440 |
Why?
|
| Stress, Psychological | 3 | 2009 | 229 | 0.430 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2004 | 23 | 0.430 |
Why?
|
| Stomach | 4 | 2007 | 43 | 0.430 |
Why?
|
| Pouchitis | 1 | 2013 | 1 | 0.420 |
Why?
|
| Duodenal Diseases | 2 | 2008 | 7 | 0.380 |
Why?
|
| Oxidative Stress | 2 | 2013 | 671 | 0.360 |
Why?
|
| Capsule Endoscopy | 2 | 2008 | 7 | 0.350 |
Why?
|
| Stress, Physiological | 2 | 2009 | 96 | 0.340 |
Why?
|
| Acetylcholine | 5 | 1994 | 73 | 0.340 |
Why?
|
| Histamine | 2 | 2007 | 10 | 0.330 |
Why?
|
| Tyrphostins | 2 | 2007 | 4 | 0.310 |
Why?
|
| Antioxidants | 2 | 2008 | 224 | 0.310 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2008 | 78 | 0.310 |
Why?
|
| Liver Failure, Acute | 1 | 2008 | 4 | 0.290 |
Why?
|
| Brunner Glands | 1 | 2008 | 1 | 0.290 |
Why?
|
| Duodenitis | 1 | 2008 | 2 | 0.290 |
Why?
|
| Dinoprostone | 1 | 2008 | 42 | 0.290 |
Why?
|
| Helicobacter pylori | 1 | 2008 | 18 | 0.290 |
Why?
|
| Helicobacter Infections | 1 | 2008 | 17 | 0.290 |
Why?
|
| Clonixin | 1 | 2008 | 1 | 0.280 |
Why?
|
| Veterinary Drugs | 1 | 2008 | 2 | 0.280 |
Why?
|
| Peptic Ulcer | 1 | 2008 | 11 | 0.280 |
Why?
|
| Ethanol | 3 | 2004 | 124 | 0.280 |
Why?
|
| Collagenases | 1 | 2007 | 5 | 0.270 |
Why?
|
| Gastroparesis | 1 | 2007 | 4 | 0.270 |
Why?
|
| Carbachol | 6 | 1994 | 18 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 95 | 0.250 |
Why?
|
| Epithelial Cells | 2 | 2007 | 256 | 0.250 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 282 | 0.230 |
Why?
|
| Indomethacin | 2 | 2003 | 15 | 0.230 |
Why?
|
| Intestinal Fistula | 1 | 2003 | 3 | 0.210 |
Why?
|
| Jejunal Diseases | 1 | 2003 | 3 | 0.210 |
Why?
|
| Humans | 24 | 2024 | 28585 | 0.210 |
Why?
|
| Intestinal Mucosa | 5 | 2008 | 197 | 0.210 |
Why?
|
| Fistula | 1 | 2003 | 17 | 0.210 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2003 | 24 | 0.210 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 74 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2006 | 611 | 0.200 |
Why?
|
| Substance P | 1 | 2003 | 6 | 0.200 |
Why?
|
| Drug Therapy, Combination | 3 | 2008 | 208 | 0.200 |
Why?
|
| Middle Aged | 11 | 2024 | 7310 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 285 | 0.180 |
Why?
|
| Cholinergic Fibers | 2 | 1994 | 5 | 0.170 |
Why?
|
| In Vitro Techniques | 7 | 2004 | 242 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2024 | 301 | 0.160 |
Why?
|
| Duodenum | 1 | 2000 | 18 | 0.160 |
Why?
|
| Inflammation | 1 | 2024 | 642 | 0.160 |
Why?
|
| Rats, Inbred Strains | 10 | 1992 | 63 | 0.150 |
Why?
|
| Eating | 2 | 2007 | 70 | 0.150 |
Why?
|
| Colonoscopy | 3 | 2005 | 59 | 0.150 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2008 | 14 | 0.150 |
Why?
|
| Aged, 80 and over | 3 | 2008 | 2045 | 0.140 |
Why?
|
| Crohn Disease | 2 | 1996 | 31 | 0.140 |
Why?
|
| Peptones | 3 | 1992 | 7 | 0.130 |
Why?
|
| Quinazolines | 2 | 2007 | 32 | 0.130 |
Why?
|
| Genital Diseases, Male | 1 | 1996 | 9 | 0.130 |
Why?
|
| Scrotum | 1 | 1996 | 8 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2008 | 1494 | 0.120 |
Why?
|
| Adaptation, Physiological | 2 | 1994 | 173 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 269 | 0.110 |
Why?
|
| Malabsorption Syndromes | 1 | 1994 | 3 | 0.110 |
Why?
|
| Probability | 2 | 2006 | 78 | 0.110 |
Why?
|
| Receptors, Presynaptic | 1 | 1994 | 1 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 633 | 0.110 |
Why?
|
| Random Allocation | 2 | 2006 | 151 | 0.110 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 9 | 0.110 |
Why?
|
| Atropine | 4 | 1994 | 47 | 0.110 |
Why?
|
| Reference Values | 2 | 2006 | 199 | 0.110 |
Why?
|
| Calcium | 3 | 1988 | 243 | 0.110 |
Why?
|
| Prostaglandins | 2 | 2004 | 13 | 0.110 |
Why?
|
| Intestines | 1 | 1994 | 118 | 0.100 |
Why?
|
| Neurosecretion | 1 | 1993 | 3 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 2 | 2003 | 35 | 0.100 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 524 | 0.100 |
Why?
|
| Aged | 4 | 2024 | 5525 | 0.090 |
Why?
|
| Endocrine Glands | 1 | 1992 | 3 | 0.090 |
Why?
|
| Parasympathetic Nervous System | 1 | 1992 | 17 | 0.090 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1991 | 5 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2006 | 465 | 0.090 |
Why?
|
| Gastrointestinal Hormones | 1 | 1991 | 1 | 0.090 |
Why?
|
| Peptide PHI | 1 | 1991 | 1 | 0.090 |
Why?
|
| Diet Therapy | 1 | 1991 | 9 | 0.090 |
Why?
|
| Anorexia Nervosa | 1 | 1991 | 11 | 0.090 |
Why?
|
| Biopsy | 2 | 2008 | 207 | 0.090 |
Why?
|
| Electric Stimulation | 2 | 2007 | 255 | 0.090 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1991 | 3 | 0.090 |
Why?
|
| Bucladesine | 5 | 1986 | 11 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1991 | 22 | 0.090 |
Why?
|
| Organ Culture Techniques | 7 | 1988 | 56 | 0.090 |
Why?
|
| Time Factors | 3 | 2007 | 1600 | 0.080 |
Why?
|
| Rectal Diseases | 2 | 1996 | 10 | 0.080 |
Why?
|
| Neurons | 1 | 1992 | 291 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 1994 | 631 | 0.080 |
Why?
|
| Tetrodotoxin | 3 | 1995 | 12 | 0.080 |
Why?
|
| Histamine Antagonists | 1 | 2009 | 3 | 0.080 |
Why?
|
| Proton Pump Inhibitors | 1 | 2009 | 27 | 0.080 |
Why?
|
| Cyclic AMP | 3 | 1988 | 87 | 0.080 |
Why?
|
| Duodenal Ulcer | 2 | 1986 | 5 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2003 | 391 | 0.070 |
Why?
|
| Cyclooxygenase 1 | 1 | 2008 | 9 | 0.070 |
Why?
|
| Critical Illness | 1 | 2009 | 66 | 0.070 |
Why?
|
| Vitamin E | 1 | 2008 | 11 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 24 | 0.070 |
Why?
|
| Cyclic N-Oxides | 1 | 2008 | 26 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2008 | 67 | 0.070 |
Why?
|
| Ileum | 2 | 1992 | 25 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 40 | 0.070 |
Why?
|
| Intestinal Polyps | 1 | 2008 | 5 | 0.070 |
Why?
|
| Receptors, Cholinergic | 1 | 1988 | 4 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 68 | 0.070 |
Why?
|
| Norepinephrine | 1 | 1988 | 32 | 0.070 |
Why?
|
| Prostate-Specific Antigen | 1 | 2008 | 52 | 0.070 |
Why?
|
| Receptors, Adrenergic | 1 | 1988 | 10 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2008 | 104 | 0.070 |
Why?
|
| Endoscopy, Digestive System | 1 | 2008 | 19 | 0.070 |
Why?
|
| Adenoma, Islet Cell | 1 | 1988 | 1 | 0.070 |
Why?
|
| Vipoma | 1 | 1988 | 2 | 0.070 |
Why?
|
| Horses | 1 | 2008 | 35 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2003 | 478 | 0.070 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2007 | 2 | 0.070 |
Why?
|
| Famotidine | 1 | 2007 | 3 | 0.070 |
Why?
|
| Colon | 1 | 2008 | 121 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 23 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 22 | 0.070 |
Why?
|
| Gastric Emptying | 1 | 2007 | 8 | 0.070 |
Why?
|
| Myoelectric Complex, Migrating | 1 | 2007 | 9 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 86 | 0.070 |
Why?
|
| Gastrointestinal Agents | 1 | 2007 | 16 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 67 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 94 | 0.060 |
Why?
|
| Hormones | 1 | 2007 | 44 | 0.060 |
Why?
|
| Electric Stimulation Therapy | 1 | 2007 | 57 | 0.060 |
Why?
|
| Disease Progression | 1 | 2008 | 475 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 198 | 0.060 |
Why?
|
| Peroxidase | 1 | 2006 | 39 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 48 | 0.060 |
Why?
|
| Ranitidine | 1 | 2006 | 9 | 0.060 |
Why?
|
| Histamine H2 Antagonists | 1 | 2006 | 7 | 0.060 |
Why?
|
| Pirenzepine | 3 | 1994 | 8 | 0.060 |
Why?
|
| Theophylline | 2 | 1985 | 6 | 0.060 |
Why?
|
| Female | 8 | 2024 | 15472 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 164 | 0.060 |
Why?
|
| Colonic Polyps | 1 | 2005 | 17 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 1026 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2007 | 310 | 0.060 |
Why?
|
| GABA Antagonists | 1 | 2004 | 4 | 0.060 |
Why?
|
| GABA Agonists | 1 | 2004 | 4 | 0.060 |
Why?
|
| Kinetics | 3 | 1998 | 551 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2008 | 485 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 166 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2006 | 581 | 0.050 |
Why?
|
| Peptide Fragments | 3 | 1995 | 202 | 0.050 |
Why?
|
| Radioimmunoassay | 4 | 1995 | 45 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2024 | 81 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2024 | 52 | 0.050 |
Why?
|
| Risk Factors | 1 | 2009 | 2111 | 0.050 |
Why?
|
| Cytokines | 1 | 2006 | 448 | 0.050 |
Why?
|
| Deuterium | 1 | 1983 | 50 | 0.050 |
Why?
|
| Laparotomy | 1 | 2003 | 35 | 0.050 |
Why?
|
| Sympathectomy, Chemical | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immersion | 1 | 2003 | 4 | 0.050 |
Why?
|
| Nitroarginine | 1 | 2003 | 4 | 0.050 |
Why?
|
| Gastritis | 1 | 2003 | 3 | 0.050 |
Why?
|
| Nitric Oxide Donors | 1 | 2003 | 11 | 0.050 |
Why?
|
| Immobilization | 1 | 2003 | 15 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2024 | 273 | 0.050 |
Why?
|
| Intestinal Obstruction | 1 | 1983 | 9 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 56 | 0.050 |
Why?
|
| Intestinal Neoplasms | 1 | 1983 | 15 | 0.050 |
Why?
|
| Endometriosis | 1 | 1983 | 19 | 0.050 |
Why?
|
| Barium Sulfate | 1 | 1982 | 3 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2003 | 27 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 133 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 66 | 0.050 |
Why?
|
| Arginine | 1 | 2003 | 42 | 0.050 |
Why?
|
| Water | 1 | 1983 | 135 | 0.050 |
Why?
|
| Adult | 5 | 2005 | 7922 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2003 | 190 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 251 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 1988 | 548 | 0.040 |
Why?
|
| Stimulation, Chemical | 3 | 1992 | 32 | 0.040 |
Why?
|
| Dogs | 3 | 2007 | 510 | 0.040 |
Why?
|
| Colitis, Ulcerative | 1 | 2001 | 31 | 0.040 |
Why?
|
| Tryptophan | 4 | 1984 | 42 | 0.040 |
Why?
|
| Nifedipine | 2 | 1995 | 12 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 410 | 0.040 |
Why?
|
| Calcimycin | 3 | 1988 | 12 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1998 | 46 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1977 | 10 | 0.030 |
Why?
|
| Prostatic Diseases | 1 | 1996 | 3 | 0.030 |
Why?
|
| Urinary Fistula | 1 | 1996 | 2 | 0.030 |
Why?
|
| Urethral Diseases | 1 | 1996 | 6 | 0.030 |
Why?
|
| Egtazic Acid | 2 | 1988 | 10 | 0.030 |
Why?
|
| Verapamil | 2 | 1988 | 9 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1998 | 515 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 2 | 1988 | 3 | 0.030 |
Why?
|
| Abscess | 1 | 1996 | 25 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 1995 | 6 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 1998 | 667 | 0.030 |
Why?
|
| Radiography | 3 | 1988 | 203 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 1985 | 114 | 0.030 |
Why?
|
| Digestive System | 2 | 1991 | 16 | 0.030 |
Why?
|
| Jejunum | 1 | 1992 | 9 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1992 | 5 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 1992 | 7 | 0.020 |
Why?
|
| Perfusion | 1 | 1992 | 43 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 1992 | 11 | 0.020 |
Why?
|
| Muscimol | 1 | 1991 | 8 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 1991 | 7 | 0.020 |
Why?
|
| Autoradiography | 1 | 1991 | 29 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 1991 | 6 | 0.020 |
Why?
|
| Food, Formulated | 1 | 1991 | 11 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 1992 | 72 | 0.020 |
Why?
|
| Epithelium | 1 | 1991 | 40 | 0.020 |
Why?
|
| Plasma | 1 | 1991 | 32 | 0.020 |
Why?
|
| Pressure | 1 | 1992 | 90 | 0.020 |
Why?
|
| Duodenoscopy | 1 | 1991 | 1 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1992 | 301 | 0.020 |
Why?
|
| Hepatic Encephalopathy | 1 | 1989 | 5 | 0.020 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 1989 | 8 | 0.020 |
Why?
|
| Zollinger-Ellison Syndrome | 2 | 1986 | 2 | 0.020 |
Why?
|
| Sodium Morrhuate | 1 | 1988 | 1 | 0.020 |
Why?
|
| Yohimbine | 1 | 1988 | 4 | 0.020 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1988 | 6 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1988 | 13 | 0.020 |
Why?
|
| Clonidine | 1 | 1988 | 10 | 0.020 |
Why?
|
| Leucine | 1 | 1988 | 20 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 1988 | 32 | 0.020 |
Why?
|
| Satiation | 1 | 2007 | 2 | 0.020 |
Why?
|
| Ghrelin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Peptide Hormones | 1 | 2007 | 4 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2007 | 40 | 0.020 |
Why?
|
| Physostigmine | 1 | 1986 | 2 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1988 | 209 | 0.020 |
Why?
|
| Postprandial Period | 1 | 2007 | 44 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2007 | 95 | 0.020 |
Why?
|
| Leptin | 1 | 2007 | 67 | 0.020 |
Why?
|
| Bombesin | 2 | 1983 | 10 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1988 | 163 | 0.020 |
Why?
|
| Fasting | 1 | 2007 | 90 | 0.020 |
Why?
|
| Receptors, Somatostatin | 1 | 1985 | 8 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1988 | 1009 | 0.010 |
Why?
|
| Insulin | 1 | 2007 | 324 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 1983 | 3 | 0.010 |
Why?
|
| Bicuculline | 1 | 1983 | 4 | 0.010 |
Why?
|
| Receptors, GABA-A | 1 | 1983 | 18 | 0.010 |
Why?
|
| Portal Vein | 1 | 1982 | 8 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1982 | 29 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1983 | 378 | 0.010 |
Why?
|
| Obesity | 1 | 2007 | 675 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1977 | 111 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1992 | 37 | 0.010 |
Why?
|
| DNA | 1 | 1992 | 375 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 252 | 0.010 |
Why?
|
| Proteins | 1 | 1992 | 253 | 0.000 |
Why?
|
| Esophagoscopy | 1 | 1988 | 16 | 0.000 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1988 | 9 | 0.000 |
Why?
|
| Secretin | 1 | 1986 | 2 | 0.000 |
Why?
|
| Gastric Acidity Determination | 1 | 1986 | 4 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1986 | 114 | 0.000 |
Why?
|
| Decision Making | 1 | 1986 | 177 | 0.000 |
Why?
|
| Catheters, Indwelling | 1 | 1982 | 19 | 0.000 |
Why?
|
| Models, Biological | 1 | 1982 | 468 | 0.000 |
Why?
|
| Adolescent | 1 | 1986 | 3165 | 0.000 |
Why?
|